Back Hoffmann-La Roche ALS هوفمان-لا روش Arabic هوفمان-لا روش ARZ هوفمان-لا روش AZB Рош Холдинг Bulgarian Hoffmann-La Roche Catalan Hoffmann-La Roche Czech Hoffmann-La Roche Danish Hoffmann-La Roche Esperanto Hoffmann-La Roche Spanish
 | |
 | |
| Company type | Public |
|---|---|
| SIX: RO (voting) SIX: ROG (non-voting) | |
| ISIN | CH0012032048 |
| Industry | Pharmaceuticals |
| Predecessor | Hoffmann, Traub & Co. (1894) |
| Founded | 1 October 1896 |
| Founder | Fritz Hoffmann-La Roche |
| Headquarters | Basel, Switzerland |
Area served | Worldwide |
Key people |
|
| Products | Pharmaceuticals and diagnostics (List of products) |
| Revenue |  CHF 62.39 billion (2024) |
 CHF 13.42 billion (2024) | |
| CHF 9.19 billion (2024) | |
| Total assets | CHF 101.80 billion (2024) |
| Total equity | CHF 36.16 billion (2024) |
Number of employees | 103,249 (2024) |
| Subsidiaries | |
| Website | roche |
| Footnotes / references [4][5] | |
F. Hoffmann-La Roche AG, commonly known as Roche (/rɒʃ/), is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue[6] and the leading provider of cancer treatments globally.[7][8] In 2023, the company’s seat in Forbes Global 2000 was 76.[9]
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights (a pool of family shareholders 45%, and Maja Oeri a further 5% apart), with Swiss pharma firm Novartis owning a further third of its shares until 2021. Roche is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).[10]47°33′31″N 7°36′22″E / 47.558624°N 7.606018°E
- ^ "FDA Grants Roche Breakthrough Therapy Designation on Hemophilia Drug". BioPharm International. UBM. 19 April 2018. Archived from the original on 20 June 2018. Retrieved 20 April 2018.
- ^ "Executive Committee". Roche.com. F. Hoffmann-La Roche. Archived from the original on 18 April 2023. Retrieved 18 April 2023.
- ^ "Roche names new head of $13 billion diagnostics unit". Reuters. 12 December 2022. Archived from the original on 18 April 2023. Retrieved 18 April 2023.
- ^ "Finance Report 2021" (PDF). Roche Holding. 4 February 2024. Retrieved 24 August 2024.
- ^ "Finance Report 2024" (PDF). Roche Holding. 3 February 2025. Retrieved 3 February 2025.
- ^ McGlauflin, Paige (15 August 2022). "The world's 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021". Fortune. Archived from the original on 17 August 2022.
- ^ "Top 10 Oncology Pharma Companies in the World | Market Research Blog". Market Research Reports® Inc. 17 May 2019. Archived from the original on 27 September 2022. Retrieved 18 October 2020.
- ^ "Top 20 pharma companies by oncology sales - Top Pharma List - PMLiVE". pmlive.com. 16 June 2014. Archived from the original on 21 August 2023. Retrieved 18 October 2020.
- ^ "The Global 2000 2023". Forbes. Archived from the original on 29 January 2024. Retrieved 7 February 2024.
- ^ "The Pharmaceutical Industry in Figures – 2008 Edition". European Federation of Pharmaceutical Industries and Associations (EFPIA). p. 49. Archived from the original on 16 September 2008. Retrieved 25 August 2008.